Opportunities with combined modality therapy for selective organ preservation in muscle-invasive bladder cancer

Journal of Surgical Oncology
K T ColvettW U Shipley

Abstract

Combined-modality therapy for organ preservation represents an appropriate alternative to radical surgery in the management of several malignant diseases. The standard therapy for muscle-invasive bladder cancer in the United States has been radical cystectomy. Although the sequelae of radical surgery have been ameliorated somewhat by techniques for the construction of orthotopic bladders, the ideal therapy should both cure the patient of cancer and maintain a functioning natural bladder. Years of experience in Europe and Canada with bladder preservation using radiation therapy are documented. Advances in transurethral surgery technique and in the combination of radiation and chemotherapy have led to safe and effective regimens for patients with bladder cancer. Several recent trials with combined-modality therapy have established this treatment as a viable alternative to radical cystectomy in selected patients.

References

Jan 1, 1978·The Journal of Urology·K B CummingsR P Gibbons
Sep 1, 1992·The British Journal of Radiology·D J ColeJ W Hopewell
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·R RozanJ Douchez
May 1, 1992·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M FlentjeM Wannenmacher
Sep 11, 1991·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C Y FungG R Prout
Sep 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·P SminiaC Koedooder
Oct 1, 1991·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S JahnsonG Westman
Mar 1, 1991·International Journal of Radiation Oncology, Biology, Physics·R FarahR R Weichselbaum
Nov 1, 1990·International Journal of Radiation Oncology, Biology, Physics·A C Begg
Jun 1, 1986·International Journal of Radiation Oncology, Biology, Physics·P M Quilty, W Duncan
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·A Wijnmaalen, B H van der Werf-Messing
Jan 1, 1986·European Urology·J Kaneti
Jun 1, 1973·The Journal of Urology·M I Resnick, V J O'Conor
Jan 1, 1984·Scandinavian Journal of Urology and Nephrology·F LindahlK Egvad
Apr 1, 1983·International Journal of Radiation Oncology, Biology, Physics·B van der Werf-MessingW C Hop
Dec 1, 1980·British Journal of Urology·J P BlandyR A Risdon
Jun 1, 1995·International Journal of Urology : Official Journal of the Japanese Urological Association·K KoisoH van Poppel
Jan 15, 1995·International Journal of Radiation Oncology, Biology, Physics·H MameghanS Brook
Sep 30, 1994·International Journal of Radiation Oncology, Biology, Physics·J DunstA Altendorf-Hofmann
May 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·H W Herr, H I Scher
Nov 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M HoussetF Baillet
Nov 4, 1993·The New England Journal of Medicine·D S KaufmanJ T Efird
Apr 2, 1993·International Journal of Radiation Oncology, Biology, Physics·W TesterE Hammond
Sep 1, 1995·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·W De NeveJ G Ribot
Jan 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W TesterW Shipley

❮ Previous
Next ❯

Citations

Jul 1, 1998·Urologic Oncology·H TsujiiJ Shimazaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
J DunstA Altendorf-Hofmann
The New England Journal of Medicine
D RaghavanJ P Richie
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
S JahnsonG Westman
© 2021 Meta ULC. All rights reserved